Patents by Inventor Matt Husovsky

Matt Husovsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-idiotypic antibodies against anti-KLK2 antibodies
    Patent number: 12162951
    Abstract: In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a KL2B413 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include KL2B413.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: December 10, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Zemeda Ainekulu, Qiang Chen, Ellen Chi, Wilson Edwards, Matt Husovsky, Ann Lacombe, Quynh Nguyen, Paul H. Kim, H. Mimi Zhou, John T. Lee
  • Anti-idiotypic antibodies against anti-GPRC5D antibodies
    Patent number: 12030937
    Abstract: In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: July 9, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Ellen Chi, Wilson Edwards, Matt Husovsky, Ann Lacombe, Christian Martinez, H. Mimi Zhou, John T. Lee
  • ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-KLK2 ANTIBODIES
    Publication number: 20220064334
    Abstract: In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a KL2B413 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include KL2B413.
    Type: Application
    Filed: July 15, 2021
    Publication date: March 3, 2022
    Inventors: Zemeda AINEKULU, Qiang CHEN, Ellen CHI, Wilson EDWARDS, Matt HUSOVSKY, Ann LACOMBE, Quynh NGUYEN, Paul H. KIM, H. Mimi ZHOU, John T. LEE
  • ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-GPRC5D ANTIBODIES
    Publication number: 20220064284
    Abstract: In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.
    Type: Application
    Filed: July 15, 2021
    Publication date: March 3, 2022
    Inventors: Ellen CHI, Wilson EDWARDS, Matt HUSOVSKY, Ann LACOMBE, Christian MARTINEZ, H. Mimi ZHOU, John T. LEE
  • METHODS FOR SCREENING FOR MODULATORS OF GDF15-LIKE BIOLOGICAL ACTIVITY
    Publication number: 20190234935
    Abstract: A novel receptor for GDF15 was identified (GFRAL), as well as the use of this receptor in the identification or screening of GDF15 agonists or antagonists. These agonist or antagonist compounds may be used to either potentiate or suppress GDF15-like effects, respectively, at the cellular and organism levels, and may be used in treatment of metabolic diseases, including obesity, type 2 diabetes, hyperglycemia, hyperinsulinemia, dyslipidemia, diabetic nephropathy, or anorexia.
    Type: Application
    Filed: October 11, 2017
    Publication date: August 1, 2019
    Inventors: Anthony Armstrong, Stephen Beck, Jose Antonio Chavez, Chen-Ni Chin, Thai Dinh, Jennifer Furman, Matt Husovsky, Xiefan Lin-Schmidt, Shannon Mullican, Shamina Rangwala, Vicki South